Articles On Medibio (ASX:MEB)

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Small Caps, ASX 200 slide on commodities sell off Energy, resources, materials all down circa 5% off setting gains for IT et al BNPL names are back in the green   This is difficult, maudlin trade to watch. Two speed investing at its fines...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 mini streak is done, small caps crash hard Brokers at Morgan Stanley downgrade property sector  Titanium Sands pops on Sri Lankan prospects   Property, tech and healthcare stocks are leading losses up and down local markets o...

The ASX200 makes it four gains in a row The small cap index remains uninspired despite some strong individual performances HRL and 4DX deliver huge returns on Tuesday   The benchmark XJO is up by 0.6%. The little XEC index is not. The ASX...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX200 is up for a 6-week high today of 2% today US and EU share markets were up 3% and 2.6% respectively on Friday The energy and tech sectors led the charge, followed by financials   Take your mind off rising inflation and surging i...

Tech leads losses on local markets ASX 200 gives away early gains, XEC dives more than 1% again BNPL names big and small get smaller   Small Caps are sharply lower and the ASX 200 is wandering aimlessly on Wednesday as tech names tumble...

Medibio (MEB) receives firm commitments to raise $1.4 million via placement to fund its US Food and Drug Administration (FDA) application and for working capital The company will issue approximately 923.6 million shares at 0.15 cents over...

Benchmark collapses Small caps down 6% Hamelin brings hope   After a really terrific Queen’s Birthday long weekend, local markets already had a session of losses to catch up on at the open. Needless to say, they have. The benchmark took...

Medibio (MEB) enters a trading a halt, as the company prepares to raise new funds The company has not yet disclosed how much it is seeking to raise or where the funds will be directed, however these details are expected to be released by T...

Emerging markets index jumps circa 2.3% ASX200 1.4% higher Southern Cross up 215% on ‘spectacular’ and ‘unprecedented’ strikes   The Emerging Companies (XEC) index is well over 2% higher on Monday, while the ASX200 (XJO) has also ended t...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Aussie markets opened slightly ahead this morning after man of the moment Anthony Norman Albanese was sworn in as the 31st prime minister and posed for a happy ALP family pic, thus ended 10 years of conservative government. Throughout the d...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Medibio (ASX:MEB) has announced that a DSM-V 1 diagnosis will be included as a primary comparator for the purposes of assessing the efficacy of its depression algorithms, MEB-001.

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

XEC falls hard on Monday XOJ closes 1.2% lower Seafarms Group (ASX:SFG) recovers Friday losses   Australian markets fell and fell hard on Monday. The benchmark ASX200 is nudging two month lows, while the Greenback’s near 20-year high has...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

First up, ladies and gents, inflation has spiked way above what the RBA and everyone else was expecting. The headline consumer prices rose 5.1% over the year – consensus was looking at around 4.6% – which frankly would’ve been bad enough bu...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Okay, who poked the S&P/ASX Emerging Companies index (XEC) this morning? Someone woke the sleeping Spinosaurus – the largest carnivorous dinosaur on this planet – that lies at the heart of our beloved small cap thermometer. It started r...

It’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XEC) index, (down 0.6%) gave up its early gains in a topsy-turvy Monday session. Just after the close, the XJO was weepingly flat – well, up 0...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two million people. Treasurer Josh Frydenberg announced last night that Australia’s health budget will top $132bn in 2022-23, up from $62bn a decade...

ASX Emerging Companies (XEC) index has closed 0.8% lower on Thursday Monday winners: Australian Vanadium Limited (ASX:AVL), Roots Sustainable Agricultural Technologies (ASX:ROO)  Monday losers: Hawsons Iron Ore (ASX:HIO), Icannex Healthcar...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Medibio (MEB) has raises just under $730,000 from an entitlement offer for its medical research and marketing activities The company was originally seeking to raise up to $3.4 million from the entitlement offer and will continue to place a...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

And it’s back-to-back gains for the ASX 200 after commodity prices and buying more stuff in December led to a smart 3.4% gain in quarterly GDP. Heading into the close, US futures are on the up. Iron ore is smashing it – up almost 4% to a Ch...

The ASX Emerging Companies index (XEC) ran free on Tuesday, climbing over 3%, apparently unrestrained by the various macro or geopolitical issues bothering the rest of us. That said, the more gown up ASX200 also lifted on Tuesday, gaining a...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The S&P/ASX200 climbed into the close on Tuesday. Most of the 35 or so point gain (0.5%)  comes off the back of some good, steady central banking, delivered – nay, telegraphed – at 2.30pm when the Reserve Bank (RBA) left the cash rate a...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...